Back to company

EJP PHARMACEUTICAL ApS: Financial statements 2019

CVR: 87923614

EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK 566,249 compared with DKK -685,356 the year before. Equity amounted to DKK 7,585,303. The solvency ratio was 99.7%. The company had 1 employee in the financial year.

Profit/Loss
566,249 kr.
Equity
7,585,303 kr.
Total Assets
7,606,305 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019--566 t.7.6 mio.1
2018---685 t.7.1 mio.1
2017--67 t.1.3 mio.7.9 mio.0
2016--124 t.-1.6 mio.8.6 mio.-
2015--161 t.1.6 mio.10.2 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

EJP PHARMACEUTICAL ApS: The 2018 annual report is outMay 24, 2019

EJP PHARMACEUTICAL ApS has published its annual report for 2018. The net result was DKK -685,356.

About EJP PHARMACEUTICAL ApS

EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee. In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity amounted to DKK 814,282.